SCHEMBL3049189

SCHEMBL3049189

c1ccc(-c2ccc(B3OCCO3)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPL P06858 3/20 0.53
LIPG Q9Y5X9 3/20 0.53
ALDH1A1 P00352 2/20 0.41
TAAR1 Q96RJ0 2/20 0.37
MAPK1 P28482 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
HSD17B10 Q99714 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
MMP3 P08254 1/20 0.37
BCL2L1 Q07817 1/20 0.37
MGLL Q99685 2/20 0.35
FAAH O00519 1/20 0.35
NCOA3 Q9Y6Q9 1/20 0.35
ORAI1 Q96D31 1/20 0.35
ORAI2 Q96SN7 1/20 0.35
ORAI3 Q9BRQ5 1/20 0.35
TRPV6 Q9H1D0 1/20 0.35
CTRC Q99895 1/20 0.34
MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14983379 0.91 LPL (0.50) LPLLIPGALDH1A1TAAR1MAPK1
SCHEMBL4262348 0.91 LPL (0.40) LPLLIPG
SCHEMBL476956 0.85 LPL (0.35) LPLLIPGALDH1A1TDP1CA1
SCHEMBL13855239 0.84 LPL (0.36) LPLLIPG
SCHEMBL4374187 0.83 LPL (0.30) LPLLIPG
SCHEMBL4266621 0.81 LPL (0.38) LPLLIPG
SCHEMBL14983389 0.81 MAOA (0.39) LPLLIPGALDH1A1MAPK1MGLL
SCHEMBL4264326 0.80 ALDH1A1 (0.41) LPLLIPGALDH1A1MAPK1GAA
SCHEMBL4265401 0.78 LPL (0.33) LPLLIPG
SCHEMBL14983378 0.78 LPL (0.59) LPLLIPGALDH1A1TAAR1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2188246-B1 AMPHIPHILIC OXALAMIDE ORGANOGELATORS DESIGNED FOR GELATION OF ORGANIC SOLVENTS, WATER AND HYDROCARBON COMMERCIAL FUELS RUDJER BOSKOVIC INST (HR) 2015-06-17 EP claimed
US-10973835-B2 Boron-containing small molecules for inhibiting activity of a receptor-like protein tyrosine phosphatase THE PENN STATE RESEARCH FOUNDATION (US) 2021-04-13 US disclosed
CN-108368142-B Method for producing aromatic compound and palladium complex 住友化学株式会社 2021-02-19 CN disclosed
US-9825228-B2 Hyperbranched polymers, process for the preparation thereof and use thereof in electronic devices MERCK PATENT GMBH (DE) 2017-11-21 US disclosed
US-9825228-B2 Hyperbranched polymers, process for the preparation thereof and use thereof in electronic devices MERCK PATENT GMBH (DE) 2017-11-21 US disclosed
US-9825228-B2 Hyperbranched polymers, process for the preparation thereof and use thereof in electronic devices MERCK PATENT GMBH (DE) 2017-11-21 US disclosed
EP-2771386-B1 HYPERBRANCHED POLYMERS, METHODS FOR PRODUCING SAME, AND USE OF SAME IN ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2017-03-01 EP disclosed
EP-2771386-B1 HYPERBRANCHED POLYMERS, METHODS FOR PRODUCING SAME, AND USE OF SAME IN ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2017-03-01 EP disclosed
EP-2599818-B1 Silicon-containing resist underlayer film-forming composition and patterning process SHINETSU CHEMICAL CO (JP) 2017-02-01 EP disclosed
EP-2188246-B1 AMPHIPHILIC OXALAMIDE ORGANOGELATORS DESIGNED FOR GELATION OF ORGANIC SOLVENTS, WATER AND HYDROCARBON COMMERCIAL FUELS RUDJER BOSKOVIC INST (HR) 2015-06-17 EP disclosed
US-20130137271-A1 SILICON-CONTAINING RESIST UNDERLAYER FILM-FORMING COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2013-05-30 US disclosed
US-20130137271-A1 SILICON-CONTAINING RESIST UNDERLAYER FILM-FORMING COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2013-05-30 US disclosed
WO-2013060411-A1 HYPERBRANCHED POLYMERS, METHODS FOR PRODUCING SAME, AND USE OF SAME IN ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2013-05-02 WO disclosed
WO-2013060411-A1 HYPERBRANCHED POLYMERS, METHODS FOR PRODUCING SAME, AND USE OF SAME IN ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2013-05-02 WO disclosed
US-7799440-B2 Organic electroluminescent device and host material of luminescent and hole-blocking material thereof CHI MEI OPTOELECTRONICS CORP. (TW) 2010-09-21 US disclosed
US-20100218414-A1 AMPHIPHILIC OXALAMIDE ORGANOGELATORS DESIGNED FOR GELATION OF ORGANIC SOLVENTS, WATER AND HYDROCARBON COMMERCIAL FUELS RUDER BOSKOVIC INSTITUTE (HR) 2010-09-02 US disclosed
EP-2188246-A2 AMPHIPHILIC OXALAMIDE ORGANOGELATORS DESIGNED FOR GELATION OF ORGANIC SOLVENTS, WATER AND HYDROCARBON COMMERCIAL FUELS RUDJER BOSKOVIC INSTITUTE (HR) 2010-05-26 EP disclosed
WO-2009030964-A9 AMPHIPHILIC OXALAMIDE ORGANOGELATORS DESIGNED FOR GELATION OF ORGANIC SOLVENTS, WATER AND HYDROCARBON COMMERCIAL FUELS RUDJER BOSKOVIC INSTITUTE (HR) 2010-03-04 WO disclosed
WO-2009030964-A2 AMPHIPHILIC OXALAMIDE ORGANOGELATORS DESIGNED FOR GELATION OF ORGANIC SOLVENTS, WATER AND HYDROCARBON COMMERCIAL FUELS RUDJER BOSKOVIC INSTITUTE (HR) 2009-03-12 WO disclosed
US-20070015005-A1 Organic electroluminescent device and host material of luminescent and hole-blocking material thereof CHI MEI OPTOELECTRONICS CORP. (TW) 2007-01-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10973835-B2 Boron-containing small molecules for inhibiting activity of a receptor-like protein tyrosine phosphatase PTPRO, PTPRR, PPP1R1B LPL 3553/4885LIPG 4059/4885ALDH1A1 1092/4885
US-20100218414-A1 AMPHIPHILIC OXALAMIDE ORGANOGELATORS DESIGNED FOR GELATION OF ORGANIC SOLVENTS, WATER AND HYDROCARBON COMMERCIAL FUELS OAT, OTC, HOGA1 LPL 3439/4885LIPG 1376/4885ALDH1A1 1271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.